Kanawha Capital Management LLC decreased its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 16.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,356 shares of the company’s stock after selling 3,607 shares during the quarter. Kanawha Capital […]